Emergence of blockbuster-level obesity drug, but Furing and Xenical decrease narrowly
It was the year that the market has shown enormous interests on newly-launched obesity treatments after a long time.
Belviq, which acquired FDA’s approval in 13 years, has suddenly became a leading product as introduced by Ildong Pharm since the last March.
The emergence of Belviq was transferr...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
